Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00344630 · ClinicalTrials.gov registry record · NA

TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?

A NA study of Coronary Artery Disease, sponsored by Boston Scientific Corporation.

Completed
Registry status
NA
Development phase
2,500
Enrollment target
1
Study location

NCT00344630 is a NA study of Coronary Artery Disease that has completed, run by Boston Scientific Corporation. The registered enrollment target is 2,500 participants, above the 1,276-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00344630, a NA study of Coronary Artery Disease, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
NA
Development phase
2,500 participants
Enrollment target
1
Study location

Study Summary

To compare the relative efficacy and safety of the TAXUS Express2 stents and the Cypher stents among a broad, unselected patient population treated in a nationwide, multi-center clinical registry representative of 'real-world,' contemporary clinical practice. A secondary objective is to examine performance of the two stents in pre-specified subgroup populations and examine regional and national patterns in outcomes.

Conditions Studied

Interventions

  • DEVICE TAXUS Stent and Cypher Stent

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2006-05
Est. Completion 2006-06
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT00344630

The ClinicalTrials.gov registry entry for NCT00344630 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,276-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% higher). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which TAXUS Stent and Cypher Stent is the first listed.

NCT00344630 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00344630 about?

NCT00344630 is a clinical study titled "TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?". To compare the relative efficacy and safety of the TAXUS Express2 stents and the Cypher stents among a broad, unselected patient population treated in a nationwide, multi-center clinical registry representative of 'real-world,' contemporary clinical practice. A secondary objective is to examine perf...

What is the current status of trial NCT00344630?

This trial is currently completed. It is a NA study. The enrollment target is 2,500 participants. The study started on 2006-05. Estimated completion is 2006-06.

What conditions does trial NCT00344630 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT00344630?

The interventions under investigation include: TAXUS Stent and Cypher Stent (DEVICE).

Who is sponsoring clinical trial NCT00344630?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00344630 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.